Evidence map›Paper›PMID 37514032›Full record

ArticlePharmaceutics2023

Nedjma Labani, Florence Gbahou, Marc Noblet, Bernard Masri, Olivier Broussaud, Jianfeng Liu, Ralf Jockers

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Nedjma LabaniCellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of Ministry of Education, School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Florence GbahouInstitut Cochin, CNRS, INSERM, University of Paris, F-75014 Paris, France.
Marc NobletScience Hub, Sanofi Consumer Healthcare, F-75017 Paris, France.
Bernard MasriInstitut Cochin, CNRS, INSERM, University of Paris, F-75014 Paris, France.ORCID 0000-0002-4027-2604
Olivier BroussaudScience Hub, Sanofi Consumer Healthcare, F-75017 Paris, France.
Jianfeng LiuCellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of Ministry of Education, School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Ralf JockersInstitut Cochin, CNRS, INSERM, University of Paris, F-75014 Paris, France.ORCID 0000-0002-4354-1750
Centre National de la Recherche Scientifique · FRSanofi (France) · FRHuazhong University of Science and Technology · CN

Funding

Centre National de la Recherche Scientifique Centre National de la Recherche ScientifiqueFondation pour la Recherche Médicale Fondation pour la recherche medicaleHuazhong University of Science and Technology Chinese scholarship CouncilInserm InsermLigue Nationale Contre le Cancer Ligue contre le cancerSanofi (France) sanofi
6 · The paper itself

Abstract

Melatonin is a tryptophan derivative synthesized in plants and animals. In humans, melatonin acts on melatonin MT

Indexed as

depressionGPCRinsomniamelatoninplant extractssignalling

Identifiers

PMID37514032
PMCPMC10386454
OpenAlexW4382677405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.